Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

ARQ-151 cream 0.05% - Phase 2 | ARQT Pipeline | CatalystAlert

ARQ-151 cream 0.05%

Phase 2

Arcutis Biotherapeutics, Inc. (ARQT)

17%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Jun 2026~

ARQTPhase 2Phase 2

ARQ-151 cream 0.05% Phase 2 Results Expected

ARQ-151 cream 0.05% • Atopic Dermatitis (Eczema)

Drug Information

Target Indication

Atopic Dermatitis (Eczema)

Clinical Trial

Last updated: 12/4/2025

Developer

ARQT

Arcutis Biotherapeutics, Inc.

Biotechnology•North America•NASDAQ